SCM

Sio Capital Management Portfolio holdings

AUM $249M
1-Year Est. Return 117.71%
This Quarter Est. Return
1 Year Est. Return
+117.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
-$81M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1 +$14.2M
2 +$11.2M
3 +$9.06M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$7.08M
5
MMS icon
Maximus
MMS
+$5.6M

Top Sells

1 +$35.6M
2 +$21.2M
3 +$19.5M
4
TFX icon
Teleflex
TFX
+$14.9M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$10.9M

Sector Composition

1 Healthcare 83.62%
2 Industrials 15.44%
3 Technology 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMS icon
1
Maximus
MMS
$4.7B
$38.5M 14.69%
548,086
+79,734
IRON icon
2
Disc Medicine
IRON
$3.31B
$15.1M 5.76%
284,787
+211,276
GMED icon
3
Globus Medical
GMED
$7.92B
$14.5M 5.54%
245,570
+38,570
CNC icon
4
Centene
CNC
$17.4B
$14.2M 5.44%
+262,500
MRK icon
5
Merck
MRK
$209B
$13.8M 5.26%
173,951
-96,645
DRUG
6
Bright Minds Biosciences
DRUG
$466M
$13.4M 5.11%
512,338
+4,776
NBIX icon
7
Neurocrine Biosciences
NBIX
$13.7B
$12.7M 4.84%
100,725
-86,848
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$10.1B
$12.4M 4.73%
225,114
+83,980
ANNX icon
9
Annexon
ANNX
$348M
$9.83M 3.75%
4,095,764
+697,978
SNY icon
10
Sanofi
SNY
$123B
$9.06M 3.46%
+187,500
TYRA icon
11
Tyra Biosciences
TYRA
$783M
$7.75M 2.96%
810,274
+393,657
ANIP icon
12
ANI Pharmaceuticals
ANIP
$2.07B
$7.37M 2.81%
112,923
+25,625
EWTX icon
13
Edgewise Therapeutics
EWTX
$1.57B
$7.08M 2.7%
+539,730
AVR
14
Anteris Technologies
AVR
$180M
$6.97M 2.66%
1,839,022
-530,938
SEPN
15
Septerna Inc
SEPN
$980M
$6.18M 2.36%
584,435
-204,235
AORT icon
16
Artivion
AORT
$1.97B
$4.94M 1.89%
158,736
+37,558
DNTH icon
17
Dianthus Therapeutics
DNTH
$1.41B
$4.4M 1.68%
236,070
+119,073
PRQR icon
18
ProQR Therapeutics
PRQR
$303M
$4.23M 1.62%
2,075,139
+20,546
PMVP icon
19
PMV Pharmaceuticals
PMVP
$76.3M
$3.96M 1.51%
3,735,396
AVNS icon
20
Avanos Medical
AVNS
$528M
$3.54M 1.35%
288,849
+2,860
MRUS icon
21
Merus
MRUS
$7.18B
$3.3M 1.26%
+62,719
AQST icon
22
Aquestive Therapeutics
AQST
$850M
$3.14M 1.2%
947,489
+555,860
VTYX icon
23
Ventyx Biosciences
VTYX
$279M
$2.8M 1.07%
1,307,964
-1,274,691
MBX
24
MBX Biosciences
MBX
$587M
$2.75M 1.05%
+241,000
IDYA icon
25
IDEAYA Biosciences
IDYA
$2.4B
$2.61M 1%
124,230
+1,230